Xtant Medical Holdings, Inc.
XTNTStock
$0.44−27.92%52W
Market Cap$63.46M
P/E12.76x
Div yield—
Beta-0.16
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-47.40%
Price vs S&P 500 (4W)-1.31%
VGM Score60.18
Market Capitalization$63.46M
P/E Ratio (Annual)12.76x
Earnings Surprise History
Q1 26-0.02est. -0.02
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.25
4.22
4.22
4.22
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
XTNTXtant Medical Holdings, Inc. | A | C | C | $0.44 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Xtant Medical Holdings develops and commercializes orthobiologics and spinal implant systems for complex spinal fusion, deformity, and degenerative procedures. Its product portfolio includes OsteoSponge, OsteoSelect Plus, OsteoWrap, and 3Demin allografts, sold to orthopedic spine surgeons and neurosurgeons. The company generates the majority of its revenue from the U.S. market.